© Copyright Nostre Net
Vaccination is encouraged by governments and institutions as
it enhances immunity against diseases, yet, there is insufficient vaccination
coverage in Middle East & Africa market. The persisting vastness of this
gap between demand and supply will drive the market growth for the next few
years. Market Research Report (MRFR) has revealed in its latest the human
vaccines market Report in Middle East & Africa will reach a record
level of USD 5.46 Bn by 2022 from USD 2.8 Bn in 2015. The market will exhibit a
robust CAGR of 11.8% across the projection period.
The hindrances to market growth that overshadows immense
potential exhibited by the market to some extent are – lack of awareness, side
effects of vaccination, declining profitability in vaccine manufacturing,
eradication of diseases, difficulty in producing vaccines for microbes with
high mutations such as HIV, etc.
Regional Analysis:
The most significant share of revenue in Middle East &
Africa region will be generated from U.A.E. due to its speeding pace of
development in the healthcare sector, rapid urbanization, rise in healthcare
expenditure, etc. The growing awareness about the diseases and the possibility
of prevention has catapulted the demand in the region. Egypt trails U.A.E’s
share of revenue contribution and is expected to retain its position for the
next six years.
The market in Africa holds tremendous potential for growth
as there is a massive gap between the need and access which will catalyze the
demand in the market for the next few years. Furthermore, the frequent outbreak
of diseases and significant death rate due to lack of proper vaccination has
motivated the organizations such as World Health Organization (WHO) to
undertake initiatives and spiral market expansion. According to WHO, in Africa,
30 million children under-five age group fall sick due to diseases that can be
prevented through proper vaccination, and of these, over half a million die.
Owing to the poor vaccination coverage, the market in Africa is expected to
grow at the fastest pace, especially in Sub Saharan regions.
Competitive Dashboard:
The key players profiled by Market Research Future (MRFR) in
its report are Merck & Co. Inc., Sanofi Pasteur, Inc., Bharat Biotech,
Valeant Pharmaceuticals, AstellasPharma Inc., GlaxoSmithKline Plc., Pfizer,
Inc., AstraZeneca Plc., Shenzhen Kangtai Biological Products, Emergent
Biosolutions Inc., and, Panacea Biotec. The players strive to penetrate the
market and tap the unexplored opportunities available in the market by the
employment of strategies such as collaboration with government institutions,
widening access of vaccines in remote areas, creating awareness, etc.
Human Vaccines Market Segmentation:
By technology, the human
vaccines market Trends in Middle East & Africa has been segmented into
attenuated, inactivated, toxoid, conjugate & subunit, and, recombinant DNA.
By disease indication, the human vaccines market is
segmented into pneumococcal, influenza, hepatitis, rotavirus, DTP, polio, and,
others.
By type, the market for human vaccines has been segmented
into prophylactic and therapeutic.
By composition, the market has been segmented into mono
vaccine and combination vaccines.
By end user, the market is segmented into children and
adults.
By route of administration, the market has been segmented
into oral, injectable and other.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Highlights
Middle-East and Africa Stroke Diagnosis and
Treatment Market was estimated around US$ 186.4 million in 2015 and is expected
to reach US$ 289.7 million by 2022 at a CAGR of 6.5% by 2030. There are several
factors which are prohibiting the growth of the market such as high cost of
treatment and drugs, lack of early treatment, lack of awareness and healthcare
facilities particularly in African countries etc.
The Middle-East and Africa Stroke
Diagnosis and Treatment Market Trends has been evaluated as moderately
growing market and it is expected that the market will continue to grow at same
pace in the near future. Stroke affects blood supply to brain. Blood
vessel that carries oxygen and nutrients to the brain is either blocked by a
clot or bursts is the cause of stroke. Due to this brain cells starting to die.
Ischemic strokes occur due to narrowing or blocking of arteries to the brain
while Hemorrhagic strokes are caused by blood vessels in and around the brain
bursting or leaking. There are some symptoms like problem in speaking,
inability to move etc.
Stroke Diagnosis and Treatment Market
Players:
There are plenty of large and small market
players which operates in Middle East and Africa market as well as all over the
globe. King Faisal Specialist Hospital and Research Centre (Saudi Arabia),
Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar),
American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), Abbott (US),
Johnson & Johnson Services, Inc. (US), GE Healthcare (UK), Koninklijke
Philips N.V. (Netherlands), Hitachi, Ltd. (Japan)
Regional Analysis:
Considering the Middle-East and Africa
Stroke Diagnosis and Treatment Market scenario, UAE region is believed to be
the largest market for Middle-East and Africa Stroke Diagnosis and Treatment.
Moreover Saudi Arabia market is also growing and second largest market for
Stroke Diagnosis and Treatment. On the other hand, Egypt market is expected to
grow at the steady pace in the Middle-East and Africa Stroke Diagnosis and
Treatment during the forecasted period. Rest of the Middle East and Africa
region is likely to have a limited but steady growth in the market.
Segmentation:
Middle-East and Africa Stroke
Diagnosis and Treatment market Report has been segmented on the basis of
type which comprise Ischemic strokes, Hemorrhagic strokes, and others. On
the basis of diagnosis the market is segmented into Blood tests, Computerized
tomography scan, Magnetic resonance imaging, Carotid ultrasound, cerebral
angiogram, Echocardiogram, and Others. On the basis of stroke
treatment it is segmented into
cerebral thrombosis, Surgical clipping, endovascular embolization, Angioplasty
and stents, Surgical AVM removal, Intracranial bypass, Stereotactic
radiosurgery, and others.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Overview:
The osteoporosis
drugs market Growth is estimated as 12,204.34 million values in the
forecast period 2022-2030, growing with a CAGR of 3.40% claims Market Research
Future (MRFR) in a detailed study. Booming urbanization and technological
advancements may have a lot to do with the progressing world, but they have
some adverse effects too. Osteoporosis is one such side-effect of the
fast-evolving lifestyle and the inflating osteoporosis drugs market is a direct
result of that. The market is about to witness a moderate CAGR of 4.7% during
the forecast period.
Drivers and Restraints:
Osteoporosis follows a genetic map in
targeting people. The Caucasians are more susceptible to osteoporosis, and the
Asians come next. Whereas the Africans are the least in number to suffer from
this disease. Along with this gender bias, a rise in geriatric population,
alcoholism and smoking, the prevalence of various disease such as cancer,
autoimmune disorders, thalassemia, hormonal and disorders are also affecting
the bone condition of the mass.
Adoption of a sedentary lifestyle triggered
by work-related pressures and technological advancements is also one of the chief
driving force for the osteoporosis drug market. Furthermore, women are more
prone to this disease. This has given rise to awareness and technological and
medical awareness which also giving the market a much needed thrust.
However, blockbuster drugs losing patents,
generic drugs penetrating the market and creating fragments in the market, and
side-effects of present therapies can bottleneck the market growth. But
patients are now quickly realizing its importance and how it can lead to
further damages such as hip fractures which will bring back the wind in the
market’s favor.
Market Dashboard:
The market is mainly getting driven by
mergers and acquisitions. For instance, Novartis has recently acquired AveXis,
Inc. On the other hand, F. Hoffmann La Roche Ltd. reached an agreement with
Foundation Medicine regarding a definitive merger.
Some of the key players in this market are
Eli Lilly and Company, Merck & Co., Novartis International AG, Amgen Inc.,
F. Hoffmann La Roche Ltd., Pfizer Inc., Novo Nordisk, Teva Pharmaceutical
Industries Ltd. and others.
Regional Analysis:
The global osteoporosis drug market covers
the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa
(MEA).
The Americas has the largest market owing
to a rising geriatric population and advanced healthcare setup. Also, the
reimbursement policies are pretty patient-friendly resulting in the growth of
the market. People here are more aware of the consequences, that is why they
prefer timely action. Hence, the market is snowballing.
Europe is second in the market and technologically
advanced healthcare sector is proving to be a boon for the market. Rising
number of population with disposable income and easy reimbursement policies act
as a market booster.
The APAC comes next where China and India
are expected to play significant role. These two countries have a huge
population base, and the market is benefitting much from their very
well-structured healthcare sector.
The MEA is expecting the least growth.
Healthcare sector is not that developed, and people act ignorant. Reimbursement
policies are not that well-formed. These are factors holding the market back.
Segmentation:
The global osteoporosis
drug market segmentation by drug class, route of administration and gender.
By osteoporosis medications, the market can
be segmented into bisphosphonates, calcitonin’s, selective estrogen receptor
modulators (SERMS), parathyroid hormone (PTH) and others. Bisphosphonates are
currently leading the market. The drug is the most commonly prescribed medicine
resulting in the medicine capturing almost half of the market.
On the basis of route of administration,
the market comprises oral, injectable and others.
Based on gender, the market comprises male
and female. However, women are more prone to this disease. As per the studies
of the International Osteoporosis Foundation (IOF), worldwide over a billion
women are now suffering from the disease.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Analysis
The Healthcare
Biometrics market Report size was valued USD 26.9 billion in 2021 and is
expected to reach USD 78.4 billion by 2030 at 22.3% CAGR during the
forecast period 2022-2030. Biometrics has changed the look and perception of
the healthcare domain. Healthcare biometrics are various biometric applications
that are used in clinics and hospitals for monitoring patient’s health.
Healthcare organizations mainly clinical research organizations, diagnostic laboratories,
health insurers, manufacturing companies and hospitals are its potential users.
The healthcare officials these days are leveraging unique ways to use the
biometrics techniques namely iris scanners, palm vein readers, finger print
scanners, facial recognition solutions amid others. Decrease in inventory
theft, control on medical frauds, safe data recording and integrity of patient
identity are the distinct benefits that biometrics offer. Implementing such
emerging technologies are making it simpler for payers, practices, hospitals
and other forms of healthcare organizations in recognizing individual patients
and matching the medical data of the patient that holds considerable
promise.
There are many factors that is fueling the growth of the healthcare
biometrics market. The different market trends and factors in this market
according to an analysis performed by Market Research Future (MRFR) include
increasing healthcare IT application, burgeoning need for cyber security,
increasing biometric development that caters to healthcare facilities, safe
treatment, increasing incidences of medical identity theft and healthcare fraud,
growing population, initiatives taken by the government to support biometrics
implementation in healthcare facilities and improving economic conditions. On
the contrary, factors such as soaring expenditure of biometric devices coupled
with issues associated to the use of this technology may limit healthcare
biometrics market growth.
Market Segmentation
In the Market Research Future (MRFR) report, the healthcare
biometrics market has been segmented on the basis of technologies, applications
and end-users.
Based on technologies, it is segmented into palm geometry
recognition, iris recognition, behavioral recognition, vein recognition,
fingerprint recognition, face recognition and others. Of these, fingerprint
recognition will have the maximum share in the healthcare biometrics
market.
Based on applications, the healthcare biometrics market is
segmented into data security, medical record management, patient monitoring,
patient identification and others. Of these, medical record management will
have the largest market share.
Based on end users, it is segmented into healthcare institutes,
research laboratories, hospitals and others. Of these, hospitals will rule the
market during the forecast period.
Regional Analysis
Based on region, the healthcare
biometrics market Statisticscovers
growth opportunities and latest trends across Europe, North America, Asia
Pacific and Rest of the World. Of these, North America will garner a huge
prominence in the market owing to the growing demand for the regulatory
requests and the well-established healthcare domain. Besides, factors such as
the proliferating healthcare insurance industry, extensive use of biometrics in
hospitals and rising digital advancements in the medical technology,
significance of electronic medical records and need for user-friendly software
are driving the growth of the market here. US is the largest contributor as it
is backed with data security, patient monitoring, medical record management,
patient identification and developments in authentic solutions. The healthcare
biometrics market in Europe is highly lucrative and grabs the second position
owing to the increasing need for healthcare biometrics across the region. The
other factors that are contributing to the growth of the market here include
the resurging economy and increased funding. In the APAC region, the healthcare
biometrics market is emerging rapidly with high growth opportunities owing to
the burgeoning healthcare sector, rapidly developing technologies and biometric
models, improving economic conditions and market penetration.
Competitive Analysis
The healthcare biometrics market is fragmented and highly
competitive due to the existence of various small and big market players
together with new participants churning the competition. The leading players
are implementing strategic trends to expand the business in the emerging
markets. They are laying emphasis on optimized situational cognizance for
customers to ensure their mission success. The matured players with the help of
different strategies namely innovations, mergers and acquisitions and
collaboration are constantly seeking market expansion. These players are
investing increasingly in research and development activities and developing
cost-effective product range. They possess cutting edge facilities for
developing software and strong distribution and sales network that have helped
them in gaining a leadership position in the healthcare biometrics market. The
marketers that are operating in clinical practice management are laying
emphasis on generating inbound leads more than ever.
Key Players
Leading players profiled in the healthcare biometrics market
include Imprivata Inc, Integrated Biometrics, Suprema, Inc., Crossmatch
Technologies Inc., Bio-Key International, Inc., NEC Corporation, Morpho (A
Subsidiary of Safran SA), BioEnable Technologies, Fujitsu Limited, and 3M
Cogent Inc.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Overview
As per the reports published by Market
Research Future (MRFR), the worldwide ulcerative colitis market has been
recorded as a growing market. The market can be estimated to generate
remarkable worth in the coming future. Ulcerative colitis is a category of
inflammatory bowel disease (IBD) that mostly impacts the lower region of the
body such as the rectum and sigmoid colon. Diarrhea, bleeding from the rectum,
belly pain, and cramps are some of the common signs of ulcerative colitis
market. As per the studies conducted by the Centers for Disease Control, global
prevalence of ulcerative colitis has been recorded to be witnessing 0.5 to 24.5
cases per 100,000 people every year. Chances of recurrence of the ailment’s
signs is also high. The Colitis Foundation of America stated that almost 30% of
people on remission are likely to suffer from the ailment seethe in the future,
right after the cure and remission.
The ulcerative
colitis market Growth is expected to reach USD 10.2 billion by 2030 at 5.2%
CAGR during the forecast period 2022-2030.
Market Segmentation
Global ulcerative colitis market has been
segmented based on medication and type. Based on medication the market has been
segmented into steroids, 5-aminosalicylates, immunomodulators, biologics, and
purine analogs. Biologics are estimated to hold the largest market share.
Steroids drugs are likely to expand at the highest CAGR over the forecast
period. Based on types, the market has been segmented as proctosigmoiditis,
ulcerative proctitis, research ulcerative colitis, pancolitis or universal
colitis, fulminant colitis, and left-sided colitis. Ulcerative proctitis has
been estimated to hold the largest market share over the forecast period.
Regional Analysis
In 2016, North America was projected to
account for the largest share of the worldwide ulcerative colitis market
followed by Europe. The region is likely to continue dominating the pack over
the forecast period. In the Asia-Pacific region, China leads the ulcerative
colitis market. Improvement of healthcare facilities coupled with economic
development are accelerating the development of the market.
Key Players
Global Key
ulcerative colitis market Players has been dominated such as AbbVie Inc.,
Allergan, Inc., UCB S.A., Pfizer Inc., Takeda Pharmaceutical Company Limited,
Ferring B.V., Bayer AG, Perrigo Company plc, Janssen Biotech, Merck, and
Johnson & Johnson Services, Inc.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The use of monoclonal antibody custom
service has grown at an increased pace because of increased consumption demand.
Market concentrated reports associated with the healthcare industry amid others
recently have been made available by Market Research Future which issues
reports on this industry. The monoclonal
antibody therapy market Growth is expected to reach USD 458.1 billion at
12.8% CAGR during the forecast period 2022-2030.
The inclusive services for expression,
antibody cloning, engineering, and purification are the main factors that are
contributing to the progress of the market in the forecast period. Amplified
focus on research & development related to this market is powering the
growth of the market at an enhanced pace in the forecast period. The Monoclonal
Antibody Therapy market also has gained a significant push due to growth in the
number of cases for chronic diseases that are being detected around the world.
Global Competitive Analysis
The opportunities for growth and innovation
have increased at a rapid pace transforming the landscape of the market. The
competitors in the market have been spurred to devise strategic road-maps that
capitalize on the positive market cues. Engaging and converting prospective
opportunities is modifying the growth pace of the market considerably. The
momentum of the market’s growth has altered the competitive background of the
market. The vital trends and players have established a positive tone for development.
By guaranteeing demand and supply are in balance the competitors can unlock new
opportunities for growth. The key players and trends have created a positive
tone for development.
GenScript, Thermo Fisher Scientific,
Creative-Biolabs, Abnova Corporation, ProMab Biotechnologies Inc, Abcam plc,
Envigo, and others are the significant contenders shaping the growth of the
market in the forecast period.
Industry Segments
The monoclonal
antibody custom service market Segmentation globally on the basis of application,
type, and end-users. The type segment of the market is segmented into rabbit
custom monoclonal antibody, rat custom monoclonal antibody, and others. The
rabbit monoclonal antibody market is expected to grow at the fastest CAGR of
11.48% during the forecast period. The segmentation based on application
consists of therapeutic application, diagnostic application, and protein
purification. The diagnostic application is additionally sub-segmented into
diagnostic imaging and biochemical analysis. The biochemical analysis is
furthermore segmented into cancer, hormonal disorder, pregnancy, and infectious
diseases. The diagnostic imaging segment is moreover segmented into cancer,
cardiovascular diseases and bacterial infections. The therapeutic
application is additionally segmented into MAb as targeting agents and MAb as
therapeutic agents. The segment of end users in the market is segmented into
pharmaceutical & biotechnology companies, customized monoclonal antibodies hospital,
research & academic laboratories, and others.
Detailed Regional Analysis
The Americas region leads the market for
monoclonal antibody custom service due to the presence of a large base of the
patient population, well-developed technology, increased healthcare expenditure
and the existence of the top contenders in the market. The European region
occupies the next position in the monoclonal antibody custom service market. It
is anticipated that the backup provided by the government bodies for research
& development is fuelling the market in the European region. The Asia Pacific
region is projected to surge rapidly during the forecast period. The high
growth rate is owing to rising risk of infectious diseases in this region. The
Middle East and Africa region controls the least portion of the market due to
the existence of slow developing and economically backward countries,
particularly, in the African region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The surge in cancer diagnoses globally is
estimated to fuel the progress of the Cancer Diagnostics Market. The market's
report is efficiently analyzed as per MRFR, which provides outlooks for the
global cancer
diagnostics market ResearchReport is expected to reach USD 269.1 billion by 2030 at CAGR of 6.7% over
the projected period 2022-2030.
The advancement in diagnostic markers and
science has led to the development of the cancer diagnostics market in the forthcoming period. The improvement in
reimbursement policies is estimated to support the expansion of the tissue
diagnostics market in the impending period.
Segmental
Analysis
The
segmental overview of the cancer diagnostics market is carried out on the basis
of type, application, end user and regions. The cancer diagnostics market's
application segment comprises breast cancer, colorectal cancer, melanoma
cancer, lung cancer, prostate cancer, and liver cancer. The cancer diagnostics
market's end user segment comprises hospitals and clinics, diagnostic centers,
and research institutes. The region segment of the cancer diagnostics market
comprises of the Americas, the Middle East, Africa, Europe, and the Asia
Pacific. The type segment of the cancer diagnostics market comprises of
biomarkers testing, biopsy, imaging testing, and in-vitro diagnostic testing.
Regional
Overview
The regional examination of the cancer
diagnostics market Forecastcomprises of the Americas, the Middle East,
Africa, Europe, and the Asia Pacific. The Americas cancer diagnostics market
governed the global market due to the mounting elderly inhabitants, the firm
healthcare sector, and growing healthcare spending. The European cancer
diagnostics market held the second major part of the cancer diagnostics market.
The growing awareness about cancer, technological developments in the region,
and mounting demand for efficient handling and diagnostics for cancer is
anticipated to drive the development of the regional cancer diagnostics market.
Germany directed the largest portion in the European market for cancer
diagnostics. The Asia-Pacific cancer diagnostics market is anticipated to
register the fastest development in the cancer diagnostics market throughout
the forecast period owing to the incidence of a large patient collection and
snowballing government proposals for the growth of the healthcare sector in the
region. Nations in Asia-Pacific are implementing advanced treatment options,
which in turn powers the cancer diagnostics market growth in this region.
The market is projected to witness a period
of turbulence with the impact of the pandemic on the workforce and the economy
as a whole. The collaborative efforts of the market contenders are expected to
broaden the horizons for development in the foreseeable future. The measures
being undertaken to ensure seamless functioning of the market is estimated to
lay off in the long run. The investment towards cutting-edge technology is
anticipated to take a sharp surge with amplified funding accessibility. The
formation of strong trade relations among several regions is forecasted to have
a beneficial effect on growth. The focus on the client's needs is estimated to
be more important than before as changes in living standards can have a notable
bearing on the popularity of certain market trends. The contenders in the
market are likely to see aggressive competition in the coming years. The
reimagined market structure is predicted to rely on a combination of robust
online selling capabilities and a capable supply chain.
The distinguished companies in the cancer
diagnostic market are Arquer Diagnostics Ltd, Illumina, Inc., Becton, Dickinson
and Company (BD), BioMark Diagnostics Inc., Biotheranostics, Exact Sciences
Corporation, Cancer Diagnostics, Inc., Agilent Technologies, Inc., Thermo
Fisher Scientific, Inc., GE Healthcare, QIAGEN N.V., Roche Diagnostics, Siemens
Healthcare, Abbott Laboratories, Inc., and Koninklijke Philips N.V., Inc.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America